Seeing Is Believing
Currently out of the existing stock ratings of Katherine Breedis, 8 are a BUY (100%).
Analyst Katherine Breedis works with a stock forecast success ratio of 25% fulfilled within 1058.5 days on average. Previously, Katherine Breedis worked at STIFEL.
Katherine Breedis’s has documented 14 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VYGR, Voyager Therapeutics at 28-Jul-2017.
Analyst best performing recommendations are on GILD (GILEAD SCIENCES).
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
85
$19.04 (28.87%)
92
11 days ago
2/7 (28.57%)
$19.49 (29.75%)
218
Hold
76
$10.04 (15.22%)
80
13 days ago
12/16 (75%)
$10.58 (16.17%)
333
Hold
78
$12.04 (18.25%)
88
16 days ago
20/23 (86.96%)
$12.58 (19.23%)
357
Hold
74
$8.04 (12.19%)
75
16 days ago
27/62 (43.55%)
$8.58 (13.12%)
841
Buy
85
$19.04 (28.87%)
90
16 days ago
4/9 (44.44%)
$19.58 (29.93%)
491
What Year was the first public recommendation made by Katherine Breedis?